Chronic myeloid leukaemia (CML)
Also known as:
- Chronic myelogenous leukaemia
- Chronic granulocytic leukaemia (CGL)
What is chronic myeloid leukaemia (CML)?
Chronic myeloid leukaemia is a rare cancer that affects the white blood cells. It is characterised by uncontrolled growth of myeloid cells in the bone marrow and their accumulation in the blood.
How rare is CML?
In the UK, less than 1,000 people are diagnosed with CML each year. It accounts for 8% of all Leukaemias in the UK.
Who does CML affect?
CML affects people of all ages but is less common in children. It is more common in men than it is in women.
Why is RareCan interested in CML?
RareCan is working to accelerate research into chronic myeloid leukaemia (CML) by making it easier for researchers to connect with people with CML. You can help us do this by becoming a RareCan member and sharing information with us about your diagnosis. We will then get in touch with you about any research opportunities that might be suitable for you.
If you are looking for further support with CML we recommend the following websites:
Blood Cancer UK
Blood Cancer UK is a community dedicated to funding research and support for those affected by blood cancers like CML.
Leukaemia Care is a UK-based charity dedicated to giving information, advice and support to anyone affected by blood cancer.